Regeneron Pharmaceuticals, Inc. Deals and Alliances Profile Introduction Regeneron Pharmaceuticals, Inc. (Regeneron) is a biopharmaceutical company engaged in the discovery, development and commercialization of pharmaceutical products for the treatment of serious medical conditions. The company's product portfolio focuses on serious debilitating medical conditions including, inflammation and immune diseases, bone and cartilage, pain, cardiovascular diseases, oncology and angiogenesis, ophthalmology, metabolic and related diseases, muscle diseases and disorders. The company has one marketed product: Arcalyst (rilonacept) Injection for subcutaneous use. It also has six clinical development programs, including three late-stage clinical programs. Global Market Directs Regeneron Pharmaceuticals, Inc. Deals and Alliances Profile is the essential source for company data and information. The profile examines the companys key business structure and operations, history and products, as well as highlights the companys major recent financial deals. Scope Provides all the crucial company information required for business and competitor intelligence needs Gives information on the companys major recent financial deals. Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.Reasons to Purchase Obtain up to date company information. Support sales activities by understanding your customers businesses. Qualify prospective partners and suppliers. Understand and respond to your competitors business structure, strategy and prospects.
|
